Legislator Case Law & Legislation
812.21 HMGLPTHLATER CH AI generated

Art. 20 Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Special provisions for imports

TPA; Chapter 2 Medicinal Products
Open official source Full Act (141 Articles) Machine-readable Markdown (.md)

Legislator summary

AI generated

Medicinal products which have been authorised, or which are not subject to authorisation, may be imported. The Federal Council may permit the importing of small quantities of non-authorised ready-to-use medicinal products by: a. private individuals for their personal use; b. medical professionals. It may allow unauthorised, ready-to-use, non-prescription medicinal products for which no alternative and equivalent medicinal product has been authorised to be imported in small quantities in accordance with Article 25 paragraph 1 letters b and c within the limits of their dispensing authority. {note: Inserted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 ( AS 2017 2745, 2018 3575; BBl 2013 1).} It may: a. stipulate that the licence to import certain medicinal products requiring a specific control for the protection of health be granted in particular cases by the Agency; b. restrict or prohibit the importing of certain medicinal products if circumstances suggest that they could be intended for illegal purposes or misuse. The Agency shall draw up a list of medicinal products for which imports shall be restricted or prohibited.

Art. 20 TPA · Special provisions for imports

Medicinal products which have been authorised, or which are not subject to authorisation, may be imported.

The Federal Council may permit the importing of small quantities of non-authorised ready-to-use medicinal products by: a. private individuals for their personal use; b. medical professionals.

It may allow unauthorised, ready-to-use, non-prescription medicinal products for which no alternative and equivalent medicinal product has been authorised to be imported in small quantities in accordance with Article 25 paragraph 1 letters b and c within the limits of their dispensing authority.

It may: a. stipulate that the licence to import certain medicinal products requiring a specific control for the protection of health be granted in particular cases by the Agency; b. restrict or prohibit the importing of certain medicinal products if circumstances suggest that they could be intended for illegal purposes or misuse.

The Agency shall draw up a list of medicinal products for which imports shall be restricted or prohibited.

← Art. 19 TPA Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Purpose Art. 21 TPA →

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →

Court Decisions Applying This Provision (34)

UE230315 · zh (Art. 20 Abs. 2 lit. a HMG)
Importation of Controlled Substance for Medical Use as "Particularly Light Case"
Cited in the reasoning to determine that the quantity imported exceeded the limit for the exception regarding the introduction of non-approved medicines for private use.
C-2652/2019 (art. 20 al. 2 let. a LPTh)
Imported Medication Seizure and Fee Upheld Due to Excessive Quantity
Autorise le Conseil fédéral à permettre l'importation, en petites quantités, de médicaments prêts à l'emploi et non autorisés à être mis sur le marché par les particuliers pour leur consommation personnelle.
C-1168/2018 (Art. 20 al. 2 let. a LPTh)
Recipient Liable for Fees on Illegal Drug Importation Despite Denial
Mentions the possibility for the Federal Council to authorize the import of small quantities of unauthorized ready-to-use medicinal products for personal use, which is also reflected in Art. 36 al. 1 aOAMéd.
C-1748/2014 (Art. 20 cpv. 1 LATer)
Graviola Leaf Powder: Medicinal Product or Food Supplement
Rule stating that only authorized or non-authorized medicines are allowed to be imported, which is the basis for prohibiting the import of the product in question.
C-1351/2013 (art. 20 al. 2 LPTh)
Confiscation of Imported Growth Hormones Upheld
Cited in relation to the import of non-authorized medicines for personal use, but deemed secondary to the LESp when a product is listed as a doping product.
C-5098/2013 (Art. 20 Abs. 1 HMG)
United States v. Shi
Used to establish that the import of the medicinal products was prohibited.
C-3182/2011 (Art. 20 Abs. 1 HMG)
Destruction of Excessive Unapproved Erectile Dysfunction Medication Upheld
This provision establishes a general prohibition on importing medicinal products that are subject to approval but not yet approved, forming the basis for the illegality of the attempted import.
C-2005/2012 (Art. 20 Abs. 1 HMG)
Importation of Unapproved Testosterone Ampoules Justifies Destruction and Fee
This provision stipulates that medicines can only be imported if they are approved in Switzerland or are not subject to approval.
C-5189/2012 (Art. 20 Abs. 1 HMG)
Imported Medication Destruction Upheld
Cited to establish that medicinal products may only be imported if they are approved in Switzerland.
C-5189/2012 (Art. 20 Abs. 2 HMG)
Imported Medication Destruction Upheld
Cited in conjunction with Art. 6 Abs. 1 AMBV to allow the import of non-approved medicinal products in small quantities for personal use.
C-6679/2011 (Art. 20 Abs. 1 HMG)
Imported Steroids and Administrative Fees
The court cited this provision to establish that medicinal products may only be imported if they are approved or not subject to approval in Switzerland, and to note that the attempted import was unlawful.
C-6679/2011 (Art. 20 Abs. 2 HMG)
Imported Steroids and Administrative Fees
The court cited this provision to refer to the exception for the import of medicinal products by individuals in small quantities for personal use.
C-8707/2010 (Art. 20 Abs. 1 HMG)
Importation of Non-Approved Medication Prohibited in Switzerland
Prohibits the import of medicinal products.
C-8707/2010 (Art. 20 Abs. 2 HMG in Verbindung mit Art. 36 Abs. 1 der Verordnung vom 17. Oktober 2001 über die Bewilligungen im Arzneimittelbereich (AMBV, SR 812.212.1))
Importation of Non-Approved Medication Prohibited in Switzerland
Provides an exception to the import ban for small quantities of medicinal products for personal use.
C-2163/2011 (art. 20 al. 1 LPTh)
Recipient Liable for Fees After Court Upholds Medication Destruction Due to Prior Unauthorized Orders
Cited as the general rule for importing authorized medications.